Francine Foss

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 645 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study

Michael S. Khodadoust, Alain H. Rook, Pierluigi Porcu et al. · Journal of Clinical Oncology · 2019 · 229 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma

Youn H. Kim, Francine Foss, Jasmine Zain et al. · Blood · 2012 · 131 citations

Medicine, Oncology, Pharmacotherapy +11

A Phase II Trial of Daily Perillyl Alcohol in Patients with Advanced Ovarian Cancer: Eastern Cooperative Oncology Group Study E2E96

Howard H. Bailey, Donna E. Levy, Linda S. Harris et al. · Gynecologic Oncology · 2002 · 76 citations

Medicine, Gynecology, Oncology +8

T-Cell Lymphomas in South America and Europe

Monica Bellei, Carlos Chiattone, Stefano Luminari et al. · Revista Brasileira de Hematologia e Hemoterapia · 2011 · 59 citations · Full text

Medicine, Hematology, Oncology +13